|
|
Article: PAREXEL Enhances Early Phase Cardiac Safety Capabilities Through Alliance With Mortara Instrument.
- Article from:
- PR Newswire
- Article date:
- November 9, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BOSTON, Nov. 9 /PRNewswire-FirstCall/ -- PAREXEL International Corporation , a leading global biopharmaceutical services provider, today announced that it has enhanced its cardiac safety capabilities for early phase clinical development through an alliance with Mortara Instrument, Inc., which manufactures and distributes electrocardiogram (ECG) devices and related technology worldwide. PAREXEL is using Mortara Instrument's Surveyor Telemetry Central System to supplement its state-of-the-art ECG equipment to support biopharmaceutical companies in improving cardiac safety assessment of new compounds.
Designed to address the growing ECG requirements of early phase ...
Related newspaper, magazine, and journal articles:
|
|
Article: Mortara Instrument is an offshoot that thrived
The Milwaukee Journal Sentinel;
July 29, 1996 ;
700+ words
... ... chief executive of privately held Mortara Instrument, buying a Mercedes roadster ... Marquette Electronics once cast on Mortara Instrument and the upstart attitude of the smaller firm. Mortara Instrument's building, sleek with wraparound ...
|
|